ATRA logo

ATRA
Atara Biotherapeutics Inc

3,659
Mkt Cap
$37.54M
Volume
121.00
52W High
$19.15
52W Low
$3.92
PE Ratio
1.57
ATRA Fundamentals
Price
$4.59
Prev Close
$4.71
Open
$4.71
50D MA
$5.06
Beta
2.22
Avg. Volume
136,424.98
EPS (Annual)
$2.57
P/B
-0.87
Rev/Employee
$8.63M
$274.38
Loading...
Loading...
News
all
press releases
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
Law Offices of Howard G. Smith Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchasedAtara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ:ATRA) securities...
Business Wire·3d ago
News Placeholder
Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Atara Biotherapeutics, Inc. (Atara or the...
Business Wire·4d ago
News Placeholder
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA Pomerantz Law Firm Announces the Filing of a Class Action Against Atara...
PR Newswire·4d ago
News Placeholder
Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) investors concerning the Companys possible violations of...
Business Wire·4d ago
News Placeholder
Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights ATRA
The DJS Law Group reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission...
Business Wire·4d ago
News Placeholder
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) violations of...
Business Wire·4d ago
News Placeholder
Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) on behalf of investors concerning the Companys possible violations of...
Business Wire·5d ago
News Placeholder
INVESTOR ALERT: Securities Class Action Filed Against Atara Biotherapeutics, Inc. Investors Encouraged to Contact Kirby McInerney LLP
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ:ATRA...
Business Wire·5d ago
News Placeholder
ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc.
ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc. ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc. PR Newswire...
PR Newswire·6d ago
<
1
2
...
>

Latest ATRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.